A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
Menactra vaccine is given to people 9 months through 55 years of age to help prevent invasive meningococcal disease (including meningitis) caused by serogroups A, C, Y, and W-135 of meningococcal bacteria. Menactra vaccine does not prevent serogroup B disease.